Package 68462-342-05

{"route": ["ORAL"], "spl_id": "617acbb5-012a-416f-bf6c-fd766a25711c", "openfda": {"upc": ["0368462343012", "0368462342015", "0368462344019", "0368462341018"], "unii": ["FD171B778Y"], "rxcui": ["905199", "905222", "905225", "905395"], "spl_set_id": ["37ba0233-ed75-498a-a067-6220da573653"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68462-342-01)", "package_ndc": "68462-342-01", "marketing_start_date": "20090529"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (68462-342-05)", "package_ndc": "68462-342-05", "marketing_start_date": "20090529"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (68462-342-10)", "package_ndc": "68462-342-10", "marketing_start_date": "20090529"}], "brand_name": "Hydralazine Hydrochloride", "product_id": "68462-342_617acbb5-012a-416f-bf6c-fd766a25711c", "dosage_form": "TABLET", "pharm_class": ["Arteriolar Vasodilation [PE]", "Arteriolar Vasodilator [EPC]"], "product_ndc": "68462-342", "generic_name": "Hydralazine Hydrochloride", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydralazine Hydrochloride", "active_ingredients": [{"name": "HYDRALAZINE HYDROCHLORIDE", "strength": "25 mg/1"}], "application_number": "ANDA090527", "marketing_category": "ANDA", "marketing_start_date": "20090529", "listing_expiration_date": "20261231"}